Skip to main content

Publications

featured publications

  • Development of Skin Rash Predicts Outcome of Anti-PD-1- and Anti-CTLA4-Based Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer or Squamous Cell Carcinoma of the Head and Neck: A Single-Center Analysis.

    Oncology research and treatment

    Authors: Karin Mayer, Wibke Briese, Johannes Blieninger, Peter Brossart, Savita Bisht, Georg Feldmann

  • Safety Performance of Healthcare Professionals: Validation and Use of the Adapted Workplace Health and Safety Instrument.

    International journal of environmental research and public health

    Authors: Lina Heier, Nikoloz Gambashidze, Judith Hammerschmidt, Donia Riouchi, Matthias Weigl, Andrew Neal, Andrea Icks, Peter Brossart, Franziska Geiser, Nicole Ernstmann

  • Intercellular cGAMP transmission induces innate immune activation and tissue inflammation in Trex1 deficiency.

    iScience

    Authors: Bianca B Jütte, Calvin Krollmann, Kevin Cieslak, Ruth-Miriam Koerber, Peter Boor, Claus M Graef, Eva Bartok, Mirko Wagner, Thomas Carell, Jennifer Landsberg, Pia Aymans, Jörg Wenzel, Peter Brossart, Lino L Teichmann

  • Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study).

    Ultraschall in der Medizin (Stuttgart, Germany : 1980)

    Authors: Elena Höhne, Florian Recker, Erik Schmok, Peter Brossart, Tobias Raupach, Valentin Sebastian Schäfer

  • Tumor rejection in mice depends on IL-9 and Th9 cells.

    Journal for immunotherapy of cancer

    Authors: Oliver Schanz, Isabelle Cornez, Sowmya Parampalli Yajnanarayana, Friederike Sophie David, Sebastian Peer, Thomas Gruber, Peter Krawitz, Peter Brossart, Annkristin Heine, Jenny Landsberg, Gottfried Baier, Dominik Wolf

  • The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.

    Cancer immunology, immunotherapy : CII

    Authors: Christiane Braun, Sebastian Schlaweck, Solveig Nora Daecke, Peter Brossart, Annkristin Heine

  • Pacritinib protects dendritic cells more efficiently than ruxolitinib.

    Experimental hematology

    Authors: Annkristin Heine, Anna Maria Wolf, Sebastian Schlaweck, Solveig Nora Daecke, Peter Brossart, Dominik Wolf

  • Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.

    European journal of haematology

    Authors: Felix Goeser, Barbara Sifft, Christoph Stein-Thoeringer, Fedja Farowski, Christian P Strassburg, Peter Brossart, Paul G Higgins, Christoph Scheid, Dominik Wolf, Tobias A W Holderried, Maria J G T Vehreschild, Marta Rebeca Cruz Aguilar

  • T follicular helper cells: linking cancer immunotherapy and immune-related adverse events.

    Journal for immunotherapy of cancer

    Authors: Dirk Baumjohann, Peter Brossart

  • Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.

    Leukemia

    Authors: Hans Salwender, Ahmet Elmaagacli, Maximilian Merz, Kaya Miah, Axel Benner, Mathias Haenel, Christian Jehn, Elias K Mai, Uta Bertsch, Igor W Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Marc S Raab, Steffen P Luntz, Britta Besemer, Markus Munder, Peter Brossart, Stephan Fuhrmann, Hans-Walter Lindemann, Katja Weisel, Jan Duerig, Hartmut Goldschmidt